RNA Vaccines

Introduction to RNA Vaccines Post COVID-19.- Self-Replicating RNA Derived from the Genomes of Positive Strand RNA Viruses.- Negative Strand RNA Virus Vectored Vaccines.- New Generation Self-Replicating RNA Vaccines Derived from Pestivirus Genome.- Trans-Amplifying RNA Vaccines Against Infectious Diseases: A Comparison with Non-Replicating and Self-Amplifying RNA.- Generation and Characterization of In Vitro Transcribed mRNA.- Production and Evaluation of Nucleoside-Modified mRNA Vaccines for Infectious Diseases.- Sequence-Optimized mRNA Vaccines Against Infectious Disease.- Design and Synthesis of Circular RNA Expression Vectors.- Electroporation of mRNA as a Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins.- A Basic Method for Formulating mRNA-Lipid Nanoparticle Vaccines in the Lab.- Messenger RNA Lipid-Based Nanoparticles: Optimization of Formulations in the Lab.- Plant Expression of Trans-Encapsidated Chimeric Viral Vaccines with Animal RNA Replicons: An Update.- Producing Plasmid DNA Template for Clinical Grade RNA Vaccine Manufacture.- Regulatory Considerations for Producing mRNA Vaccines for Clinical Trials.- Quality by Digital Design for Developing Platform RNA Vaccine Manufacturing Processes.- Nonclinical Safety Testing of RNA Vaccines.